Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-08-21FDA Approved: DULERA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Dulera (mometasone furoate/formoterol fumarate dihydrate) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2012-08-15Clinical Trial Update: The Community United to Challenge Asthma [NA]
Rush University Medical Center reports a completed clinical trial related to asthma.
-
CLINICAL_TRIALS trial_result · 2012-08-15Clinical Trial Update: The Community United to Challenge Asthma [NA]
This clinical trial update notes that the Rush University Medical Center-sponsored asthma study (NCT01061424) has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma [Phase 3]
Phase 3 trial comparing Symbicort single inhaler therapy with conventional best practice for persistent asthma.
-
FDA approval · 2012-08-13FDA Approved: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — Supplemental Application (Nephron Pharmaceuticals Corporation)
FDA approved a supplemental application for the combination inhaler ipratropium bromide and albuterol sulfate from Nephron Pharmaceuticals C…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-08-13Clinical Trial Update: Examining the Role of Vitamin D in Asthma and Chronic Obstructive Pulmonary Disease (COPD)
A Brigham and Women's Hospital trial examining the role of vitamin D in asthma and chronic obstructive pulmonary disease has completed. The …
-
FDA approval · 2012-08-09FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair Diskus (fluticasone propionate and salmeterol) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2012-08-09FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Advair HFA (fluticasone propionate and salmeterol xinafoate) submitted by GlaxoSmithKline LLC to…
-
FDA label_change · 2012-08-09FDA Approved: SEREVENT DISKUS — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for SEREVENT DISKUS (salmeterol xinafoate) from GlaxoSmithKline LLC, resulting in changes to the pro…
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Mannitol Challenge Test in Adult Asthma Patients With Fixed Dose Combinations [Phase 4]
Phase 4 clinical trial update evaluating mannitol challenge testing in adult asthma patients on fixed-dose inhaled combination therapies; th…
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Asthma in a Decentralized Patient Population: Is Traditional Disease Management Enough? [NA]
This clinical trial update notes the completion of NCT00124085, a study evaluating asthma management in a decentralized patient population t…
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: Safety and Efficacy of an H1N1 Influenza Vaccine in People With Asthma [Phase 2]
Phase 2 trial evaluating the safety and efficacy of an H1N1 influenza vaccine in people with asthma; results were posted in 2012.
-
FDA approval · 2012-08-06FDA Approved: MONTELUKAST SODIUM — Original Application (Dr.Reddy's Laboratories Limited)
FDA approves the original ANDA for Montelukast sodium from Dr. Reddy's Laboratories Limited, establishing a generic Montelukast sodium produ…
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge [Phase 4]
A Phase 4 clinical trial investigating allergic inflammation in rhinitis patients after nasal allergen challenge has completed.
-
FDA approval · 2012-08-06FDA Approved: MONTELUKAST SODIUM — Original Application (Dr.Reddy's Laboratories Limited)
FDA approved the original application for Montelukast Sodium from Dr. Reddy's Laboratories Limited (ANDA 201581). This approval makes Montel…
-
CLINICAL_TRIALS trial_result · 2012-08-03Clinical Trial Update: A Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma [Phase 2]
A Phase 2 study evaluating daily dosing with levalbuterol, racemic albuterol, and placebo in pediatric subjects with asthma has completed.
-
FDA approval · 2012-08-03FDA Approved: MONTELUKAST SODIUM — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for a generic montelukast sodium product from Rising Pharma Holdings, Inc. under ANDA 202468.
-
FDA approval · 2012-08-03FDA Approved: MONTELUKAST — Original Application (Sandoz Inc)
FDA approved Sandoz's original ANDA for montelukast, establishing a generic version of the leukotriene receptor antagonist for prevention of…
-
FDA approval · 2012-08-03FDA Approved: MONTELUKAST SODIUM — Original Application (Lannett Company, Inc.)
FDA approves the original application for Montelukast Sodium (generic montelukast) manufactured by Lannett Company, Inc. The approval enable…
-
FDA approval · 2012-08-03FDA Approved: MONTELUKAST SODIUM — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved the original application for Montelukast Sodium (generic) from Rising Pharma Holdings, expanding access to montelukast prod…
-
FDA approval · 2012-08-03FDA Approved: MONTELUKAST SODIUM — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's Montelukast Sodium as an original generic application (ANDA 201515).
-
FDA approval · 2012-08-03FDA Approved: MONTELUKAST SODIUM — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's original ANDA for montelukast sodium, establishing a generic version of montelukast for the a…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: A Study on the Effects of a Single Dose of Prednisone on Biomarkers of Allergen Responses in Asthmatics (MK-0000-175) [Phase 1]
A Phase 1 study evaluated the effect of a single dose of prednisone on biomarkers of allergen responses in asthmatics, with results posted a…
-
FDA approval · 2012-07-31FDA Approved: BUDESONIDE INHALATION — Original Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved Amneal Pharmaceuticals of New York LLC's generic budesonide inhalation under an original ANDA. The product provides a gener…
-
FDA approval · 2012-07-30FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for XOPENEX HFA (levalbuterol tartrate).